Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Collaborations
Clinical trials started for estrogen receptor agent
February 24th, 2005
Clinical trials have been initiated for the most advanced compound in the drug discovery and development collaboration between Merck & Co., Inc., and Karo Bio. The advancement of this compound, in clinical development to address an important unmet clinical need, has triggered a significant milestone payment from Merck to Karo Bio. The collaboration with Merck & Co., Inc., (MRK) was initiated in November 1997 with the objective of developing new treatments targeting estrogen receptors, which may be particularly relevant in women's healthcare, but also in other major clinical areas. The joint drug discovery phase of the...
Source: Women's Health Weekly (2005-02-24)
|
